Millie Whatley

3.6k total citations
44 papers, 2.4k citations indexed

About

Millie Whatley is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Millie Whatley has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 15 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Millie Whatley's work include Adrenal and Paraganglionic Tumors (15 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Pituitary Gland Disorders and Treatments (12 papers). Millie Whatley is often cited by papers focused on Adrenal and Paraganglionic Tumors (15 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Pituitary Gland Disorders and Treatments (12 papers). Millie Whatley collaborates with scholars based in United States, Netherlands and Germany. Millie Whatley's co-authors include Jorge A. Carrasquillo, Clara C. Chen, Karel Pacák, Alexander Ling, Karen T. Adams, Graeme Eisenhofer, Henri Timmers, Stephen L. Bacharach, Ιoannis Ilias and Karel Pacák and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Millie Whatley

44 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Millie Whatley United States	26	1.3k	1.0k	916	541	397	44	2.4k
Paxton V. Dickson United States	24	835 0.7×	354 0.3×	443 0.5×	115 0.2×	220 0.6×	101	2.0k
Lucia Martiniova United States	14	465 0.4×	322 0.3×	409 0.4×	244 0.5×	166 0.4×	26	980
Marie‐Elisabeth Toubert France	24	637 0.5×	1.2k 1.2×	264 0.3×	662 1.2×	38 0.1×	63	2.3k
Ravinder K. Grewal United States	26	815 0.6×	1.7k 1.7×	164 0.2×	773 1.4×	90 0.2×	74	2.9k
Bennett B. Chin United States	23	449 0.4×	261 0.3×	175 0.2×	845 1.6×	133 0.3×	91	1.7k
M. Ricard France	15	813 0.6×	1.9k 1.8×	97 0.1×	583 1.1×	83 0.2×	50	2.3k
Mitsunori Ohta Japan	30	1.1k 0.8×	402 0.4×	139 0.2×	203 0.4×	1.2k 3.0×	96	3.3k
Christine Sagan France	25	632 0.5×	207 0.2×	763 0.8×	468 0.9×	35 0.1×	101	2.4k
Christian Ensinger Austria	24	310 0.2×	254 0.2×	315 0.3×	255 0.5×	91 0.2×	53	1.9k
H. Richard Alexander United States	23	622 0.5×	478 0.5×	173 0.2×	82 0.2×	97 0.2×	63	1.9k

Countries citing papers authored by Millie Whatley

Since Specialization

Citations

This map shows the geographic impact of Millie Whatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Millie Whatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Millie Whatley more than expected).

Fields of papers citing papers by Millie Whatley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Millie Whatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Millie Whatley. The network helps show where Millie Whatley may publish in the future.

Co-authorship network of co-authors of Millie Whatley

This figure shows the co-authorship network connecting the top 25 collaborators of Millie Whatley. A scholar is included among the top collaborators of Millie Whatley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Millie Whatley. Millie Whatley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conlon, Kevin C., Claude Sportès, Martin W. Brechbiel, et al.. (2020). ⁹⁰ Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 35(4). 249–261. 6 indexed citations

Carrasquillo, Jorge A., Clara C. Chen, Susan Price, et al.. (2019). 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome. Clinical Nuclear Medicine. 44(12). 949–955. 6 indexed citations

Polizzotto, Mark N., Corina Millo, Thomas S. Uldrick, et al.. (2015). ¹⁸ F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus–Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters. The Journal of Infectious Diseases. 212(8). 1250–1260. 25 indexed citations

Lamart, Stéphanie, Steven L. Simon, Kazutaka Doi, et al.. (2013). Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy. Physics in Medicine and Biology. 58(24). 8739–8753. 12 indexed citations

Chen, Clara C., James C. Reynolds, Millie Whatley, et al.. (2011). False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocrine Related Cancer. 19(1). 83–93. 88 indexed citations

King, Kathryn S., Clara C. Chen, Dimitrios Alexopoulos, et al.. (2011). Functional Imaging ofSDHx-Related Head and Neck Paragangliomas: Comparison of¹⁸F-Fluorodihydroxyphenylalanine,¹⁸F-Fluorodopamine,¹⁸F-Fluoro-2-Deoxy-d-Glucose PET,¹²³I-Metaiodobenzylguanidine Scintigraphy, and¹¹¹In-Pentetreotide Scintigraphy. The Journal of Clinical Endocrinology & Metabolism. 96(9). 2779–2785. 99 indexed citations

Ilias, Ιoannis, Clara C. Chen, Jorge A. Carrasquillo, et al.. (2008). Comparison of 6-¹⁸F-Fluorodopamine PET with ¹²³I-Metaiodobenzylguanidine and ¹¹¹In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma. Journal of Nuclear Medicine. 49(10). 1613–1619. 107 indexed citations

Timmers, Henri, Graeme Eisenhofer, Jorge A. Carrasquillo, et al.. (2008). Use of 6‐[¹⁸F]‐fluorodopamine positron emission tomography (PET) as first‐line investigation for the diagnosis and localization of non‐metastatic and metastatic phaeochromocytoma (PHEO). Clinical Endocrinology. 71(1). 11–17. 60 indexed citations

Hadi, Mohiuddin, Stephen L. Bacharach, Millie Whatley, et al.. (2008). Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the “glucose-corrected” SUV. Nuclear Medicine and Biology. 35(4). 441–445. 18 indexed citations

10.

Hadi, Mohiuddin, et al.. (2007). Brown Fat Imaging with 18F-6-Fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma. Journal of Nuclear Medicine. 48(7). 1077–1083. 88 indexed citations

11.

Polis, Michael A., Richard T. Davey, Barbara Hahn, et al.. (2006). Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS. 20(7). 985–993. 62 indexed citations

12.

Rao, V. Koneti, Jorge A. Carrasquillo, Janet K. Dale, et al.. (2006). Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS). American Journal of Hematology. 81(2). 81–85. 16 indexed citations

13.

Pacák, Karel, Ιoannis Ilias, Clara C. Chen, et al.. (2004). The Role of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography and [¹¹¹In]-Diethylenetriaminepentaacetate-d-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 89(5). 2214–2221. 102 indexed citations

14.

Tan, Antoinette R., Xiaowei Yang, Stephen M. Hewitt, et al.. (2004). Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Journal of Clinical Oncology. 22(15). 3080–3090. 149 indexed citations

15.

Nowak, Miroslawa, Jorge A. Carrasquillo, Cheryl Yarboro, et al.. (2004). A pilot study of the use of 2‐[¹⁸F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 50(4). 1233–1238. 15 indexed citations

16.

Ilias, Ιoannis, Juan Yu, Jorge A. Carrasquillo, et al.. (2003). Superiority of 6-[¹⁸F]-Fluorodopamine Positron Emission TomographyVersus[¹³¹I]-Metaiodobenzylguanidine Scintigraphy in the Localization of Metastatic Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4083–4087. 169 indexed citations

17.

Danforth, David N., Luigi Aloj, Jorge A. Carrasquillo, et al.. (2002). The Role of 18F-FDG-PET in the Local/Regional Evaluation of Women with Breast Cancer. Breast Cancer Research and Treatment. 75(2). 135–146. 61 indexed citations

18.

Pacák, Karel, Graeme Eisenhofer, Jorge A. Carrasquillo, et al.. (2002). Diagnostic Localization of Pheochromocytoma. Annals of the New York Academy of Sciences. 970(1). 170–176. 34 indexed citations

19.

Libutti, Steven K., H. Richard Alexander, Peter L. Choyke, et al.. (2001). A Prospective Study of 2-[18F] Fluoro-2-Deoxy-D-Glucose/Positron Emission Tomography Scan, 99mTc-Labeled Arcitumomab (CEA-Scan), and Blind Second-Look Laparotomy for Detecting Colon Cancer Recurrence in Patients With Increasing Carcinoembryonic Antigen Levels. Annals of Surgical Oncology. 8(10). 779–786. 48 indexed citations

20.

Carrasquillo, Jorge A., Lixin Lang, Millie Whatley, et al.. (1998). Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv.. PubMed. 58(12). 2612–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact